Combination Low-Dose Tissue-Type Plasminogen Activator Plus Annexin A2 for Improving Thrombolytic Stroke Therapy

Risk of hemorrhagic transformation, incomplete reperfusion, neurotoxicity, and a short treatment time window comprises major challenges for tissue plasminogen activator (tPA) thrombolytic stroke therapy. Improving tPA therapy has become one of the highest priorities in the stroke field. This mini re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cell Neurosci
Main Authors: Jiang, Yinghua, Fan, Xiang, Yu, Zhanyang, Liao, Zhengbu, Wang, Xiao-Shu, van Leyen, Klaus, Sun, Xiaochuan, Lo, Eng H., Wang, Xiaoying
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2015
Assuntos:
Neuroscience
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4604305/
https://ncbi.nlm.nih.gov/pubmed/26528130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2015.00397
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados